Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 459
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
J Cell Biochem ; 120(10): 17975-17983, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31218739

RESUMO

BACKGROUND: Hepatocellular carcinoma (HCC) is a significant clinical challenge, and the mechanisms underlying HCC pathogenesis remain incompletely understood. Colon cancer associated transcript 1 (CCAT1), is one novel long noncoding RNA (lncRNA) which is upregulated in HCC. Autophagy is a vital process in HCC progression, and it is unknown whether CCAT1 regulates autophagy in HCC. MATERIALS AND METHODS: Immunofluorescence staining and transmission electron microscopy were used to analyze autophagy activity. Luciferase assay was performed to confirm miRNA-181a-5p (miR-181a-5p) bind CCAT1 and ATG7. RESULTS: CCAT1 levels were higher in tissue and cell lines of HCC. In function research, we found that CCAT1 facilitates HCC cell autophagy and cell proliferation. Our results show that, mechanistically, CCAT1 promotes autophagy through functioning as a sponge for miR-181a-5p, and then regulating ATG7 expression. CONCLUSION: Our findings indicate CCAT1 may play a role in regulating autophagy by sponging miR-181a-5p in HCC.


Assuntos
Proteína 7 Relacionada à Autofagia/metabolismo , Autofagia/genética , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/patologia , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/patologia , MicroRNAs/metabolismo , RNA Longo não Codificante/metabolismo , Sequência de Bases , Carcinoma Hepatocelular/ultraestrutura , Linhagem Celular Tumoral , Proliferação de Células/genética , Regulação Neoplásica da Expressão Gênica , Humanos , Neoplasias Hepáticas/ultraestrutura , RNA Longo não Codificante/genética , Regulação para Cima/genética
2.
Bull Exp Biol Med ; 167(1): 87-90, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-31177458

RESUMO

We studied the effect of lithium carbonate on hepatocellular carcinoma-29 cells in CBA male mice after injection in a dose of 20 mM along the tumor periphery. Transmission electron microscopy revealed a decrease in the volume density of the granular endoplasmic reticulum in the cell cytoplasm and an increase in the total numerical and volume density of autophagosomes and autolysosomes and zones of destruction of intracellular organelles. The ability of lithium carbonate to activate intracellular degradation processes in tumor cells and to stimulate cell death can be used to develop new combined strategies in the chemotherapy for hepatocellular carcinoma.


Assuntos
Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/ultraestrutura , Carbonato de Lítio/uso terapêutico , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/ultraestrutura , Animais , Autofagia/efeitos dos fármacos , Carcinoma Hepatocelular/tratamento farmacológico , Linhagem Celular Tumoral , Neoplasias Hepáticas/tratamento farmacológico , Camundongos , Camundongos Endogâmicos CBA , Microscopia Eletrônica de Transmissão
3.
Bull Exp Biol Med ; 167(6): 779-783, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31655987

RESUMO

Five cytological types of hepatocellular carcinoma-29 (G-29) grown in the muscle tissue of the thigh of experimental animals were identified by transmission electron microscopy; 89% of these were poorly differentiated type I-III cells. Lithium in a concentration of 20 mM produced a damaging effect on poorly differentiated G-29 cells: the number of cells with zones of intracellular component destruction and volume density of these zones increased, while volume density of cisterns of endoplasmic reticulum decreased. These results suggest that lithium carbonate can cause destructive changes in the heterogeneous population of G-29 cells during in vivo tumor development.


Assuntos
Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/ultraestrutura , Tamanho Celular/efeitos dos fármacos , Carbonato de Lítio/farmacologia , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/ultraestrutura , Animais , Carcinoma Hepatocelular/tratamento farmacológico , Diferenciação Celular , Linhagem Celular Tumoral , Técnicas Citológicas , Humanos , Injeções Intraperitoneais , Carbonato de Lítio/administração & dosagem , Neoplasias Hepáticas/tratamento farmacológico , Masculino , Camundongos , Camundongos Endogâmicos CBA , Microscopia Eletrônica de Transmissão , Ensaios Antitumorais Modelo de Xenoenxerto
4.
J Biol Chem ; 292(49): 20208-20217, 2017 12 08.
Artigo em Inglês | MEDLINE | ID: mdl-28978646

RESUMO

Impaired mitochondrial oxidative phosphorylation (OXPHOS) capacity, accompanied by enhanced glycolysis, is a key metabolic feature of cancer cells, but its underlying mechanism remains unclear. Previously, we reported that human hepatoma cells that harbor OXPHOS defects exhibit high tumor cell invasiveness via elevated claudin-1 (CLN1). In the present study, we show that OXPHOS-defective hepatoma cells (SNU354 and SNU423 cell lines) exhibit reduced expression of mitochondrial ribosomal protein L13 (MRPL13), a mitochondrial ribosome (mitoribosome) subunit, suggesting a ribosomal defect. Specific inhibition of mitoribosomal translation by doxycycline, chloramphenicol, or siRNA-mediated MRPL13 knockdown decreased mitochondrial protein expression, reduced oxygen consumption rate, and increased CLN1-mediated tumor cell invasiveness in SNU387 cells, which have active mitochondria. Interestingly, we also found that exogenous lactate treatment suppressed MRPL13 expression and oxygen consumption rate and induced CLN1 expression. A bioinformatic analysis of the open RNA-Seq database from The Cancer Genome Atlas (TCGA) liver hepatocellular carcinoma (LIHC) cohort revealed a significant negative correlation between MRPL13 and CLN1 expression. Moreover, in patients with low MRPL13 expression, two oxidative metabolic indicators, pyruvate dehydrogenase B expression and the ratio of lactate dehydrogenase type B to type A, significantly and negatively correlated with CLN1 expression, indicating that the combination of elevated glycolysis and deficient MRPL13 activity was closely linked to CLN1-mediated tumor activity in LIHC. These results suggest that OXPHOS defects may be initiated and propagated by lactate-mediated mitoribosomal deficiencies and that these deficiencies are critically involved in LIHC development.


Assuntos
Carcinoma Hepatocelular/patologia , Ácido Láctico/farmacologia , Proteínas de Membrana/metabolismo , Proteínas Mitocondriais/metabolismo , Proteínas de Neoplasias/metabolismo , Fosforilação Oxidativa , Proteínas Ribossômicas/metabolismo , Tioléster Hidrolases/metabolismo , Carcinoma Hepatocelular/ultraestrutura , Linhagem Celular Tumoral , Humanos , Invasividade Neoplásica , Fosforilação Oxidativa/efeitos dos fármacos , Consumo de Oxigênio , Ribossomos/efeitos dos fármacos , Ribossomos/patologia
5.
J Cell Biochem ; 119(10): 8600-8610, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-30015383

RESUMO

Recent research has tried to use exosomal RNAs (coding and noncoding) as potential diagnostic markers for hepatocellular carcinoma (HCC). Initially, by using bioinformatics, we selected an HCC-exosomal RNA-based biomarker panel. The choice of this panel depends on the integration of Ras-related in brain (RAB11A) gene expression and its competing endogenous network. This network includes long noncoding RNA RP11-513I15.6 (lncRNA-RP11-513I15.6) and microRNA-1262 (miR-1262). Secondly, we tried to validate the expression of this network in the sera of 60 patients with HCC in comparison with 42 chronic hepatitis C virus-infected patients and 18 healthy controls. Then we assessed the diagnostic efficiency of this panel using a receiver operating characteristic curve analysis. The panel of 3 exosomal RNA-based biomarkers (lncRNA-RP11-513I15.6, miR-1262, and RAB11A) showed excellent sensitivity and specificity in discriminating patients with HCC from patients with chronic hepatitis C virus and healthy controls. Among these 3 RNAs, serum RAB11A mRNA was the most independent prognostic factor. The selected circulatory exosomal RNA-based biomarker panel showed its ability to be used as a diagnostic and prognostic biomarker tool for HCC. Moreover, these biomarkers could be therapeutic targets.


Assuntos
Carcinoma Hepatocelular/sangue , Neoplasias Hepáticas/sangue , MicroRNAs/genética , RNA Longo não Codificante/genética , Proteínas rab de Ligação ao GTP/sangue , Análise de Variância , Biomarcadores Tumorais/sangue , Carcinoma Hepatocelular/ultraestrutura , Distribuição de Qui-Quadrado , Biologia Computacional , Exossomos/ultraestrutura , Feminino , Expressão Gênica , Hepatite C Crônica/sangue , Humanos , Estimativa de Kaplan-Meier , Neoplasias Hepáticas/ultraestrutura , Masculino , Microscopia Eletrônica de Transmissão , Pessoa de Meia-Idade , Prognóstico , RNA Mensageiro/genética , Estatísticas não Paramétricas , alfa-Fetoproteínas/análise
6.
Ultrastruct Pathol ; 42(2): 97-107, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29424576

RESUMO

Early detection of hepatocellular carcinoma (HCC) is crucial for successful therapy. The present work examined the value of ultrastructural morphometric image analysis of hepatocyte nuclei in patients with chronic hepatitis C virus (HCV) versus HCC cases with chronic HCV and the corresponding surgical tumor-free safe margins (TFMs), to highlight any early predictive signs of neoplastic cellular transformation. This work also performed an immunohistochemical assessment of cytokeratin 19 (CK19) and Ki-67-positive cells to visualize any associated proliferative activity in the examined groups. The results showed significant decrease in the hepatocyte nuclear surface areas in the HCC and TFMs versus those in the HCV cases. The hepatocyte nucleolar surface area was significantly increased in the HCC cases versus that in the HCV cases. This increase was associated with a significant increase in Ki-67-positive cells in the HCC cases compared to those in the other groups. Conversely, the mean number of CK 19-positive cells was significantly reduced in the HCC cases compared to the cell numbers in TFMs and HCV cases with severe hepatic fibrosis. Liver progenitor cells (LPCs) were discerned in the reactive ductules and canaliculo-ductular junctions that characterized TFMs. LPCs were sporadically distributed in the liver lobules and reactive bile ductules in the HCC samples. In conclusion, CK 19 represents an important marker for distinguishing between dysplastic and malignant liver nodules. Electron microscopic morphometric image analysis may be considered as adjunct factor for assessing hepatocyte malignant transformation. Wider scale studies are needed to authenticate these results.


Assuntos
Biomarcadores Tumorais/análise , Carcinoma Hepatocelular/patologia , Transformação Celular Neoplásica/patologia , Neoplasias Hepáticas/patologia , Carcinoma Hepatocelular/ultraestrutura , Carcinoma Hepatocelular/virologia , Transformação Celular Neoplásica/ultraestrutura , Hepatite C Crônica/complicações , Hepatite C Crônica/patologia , Humanos , Interpretação de Imagem Assistida por Computador , Imuno-Histoquímica , Queratina-19/análise , Queratina-19/biossíntese , Neoplasias Hepáticas/ultraestrutura , Neoplasias Hepáticas/virologia , Microscopia Eletrônica de Transmissão
7.
Bull Exp Biol Med ; 165(3): 390-393, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30006876

RESUMO

Structural changes in the liver of CBA mice were studied during the development of experimental hepatocarcinoma-29 inoculated into the hip. A decrease in the volume density of hepatocyte cytoplasm, mitochondria, endoplasmic reticulum, and lipid inclusions and an increase in the volume density of lysosomal structures during tumor growth were observed. All stages of intracellular autophagy were recorded by the method of electron microscopy. These stages included the appearance of autophagosomes, autophagolysosomes, and secondary lysosomes in the hepatocyte cytoplasm. Fragments of cytoplasm, glycogen rosettes, mitochondria, and fragments of endoplasmic reticulum with ribosomes were found in autophagosomes. The obtained data indicate the development of non-selective autophagy in the liver during distant tumor growth in aimed at the maintenance of intracellular homeostasis in hepatocytes and energy and trophic homeostasis of organism.


Assuntos
Autofagia , Carcinoma Hepatocelular/ultraestrutura , Hepatócitos/ultraestrutura , Neoplasias Hepáticas Experimentais/ultraestrutura , Animais , Autofagossomos/patologia , Autofagossomos/ultraestrutura , Carcinoma Hepatocelular/patologia , Linhagem Celular Tumoral , Retículo Endoplasmático/patologia , Retículo Endoplasmático/ultraestrutura , Hepatócitos/patologia , Injeções Intramusculares , Gotículas Lipídicas/patologia , Gotículas Lipídicas/ultraestrutura , Neoplasias Hepáticas Experimentais/patologia , Lisossomos/patologia , Lisossomos/ultraestrutura , Masculino , Camundongos , Camundongos Endogâmicos CBA , Microscopia Eletrônica , Mitocôndrias/patologia , Mitocôndrias/ultraestrutura , Músculo Esquelético
8.
Mod Pathol ; 30(6): 892-896, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28256571

RESUMO

Fibrolamellar carcinoma was first described in 1956. Subsequent large studies failed to identify cases before 1939 (the start of the World War II). This finding, combined with the presence of aryl hydrocarbon receptors on the tumor cells, have suggested that fibrolamellar carcinomas may be caused by environmental exposures that are new since World War II. To investigate this possibility, the surgical pathology files before 1939 were reviewed for hepatocellular carcinomas resected in young individuals. Two cases of fibrolamellar carcinoma were identified, from 1915 to 1924. The diagnosis of fibrolamellar carcinoma was confirmed at the histologic, ultrastructural and proteomic levels. These two fibrolamellar carcinoma cases clarify a key aspect of fibrolamellar carcinoma biology, reducing the likelihood that these tumors result exclusively from post World War II environmental exposures.


Assuntos
Carcinógenos Ambientais/efeitos adversos , Carcinoma Hepatocelular/etiologia , Exposição Ambiental/efeitos adversos , Adulto , Idoso , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/genética , Carcinoma Hepatocelular/química , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/ultraestrutura , Subunidades Catalíticas da Proteína Quinase Dependente de AMP Cíclico/genética , Proteínas de Choque Térmico HSP40/genética , Humanos , Imuno-Histoquímica , Hibridização in Situ Fluorescente , Masculino , Microscopia Eletrônica , Fatores de Risco
9.
Histochem Cell Biol ; 147(4): 415-438, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27975144

RESUMO

We studied Golgi apparatus disorganizations and reorganizations in human HepG2 hepatoblastoma cells by using the nonmetabolizable glucose analogue 2-deoxy-D-glucose (2DG) and analyzing the changes in Golgi stack architectures by 3D-electron tomography. Golgi stacks remodel in response to 2DG-treatment and are replaced by tubulo-glomerular Golgi bodies, from which mini-Golgi stacks emerge again after removal of 2DG. The Golgi stack changes correlate with the measured ATP-values. Our findings indicate that the classic Golgi stack architecture is impeded, while cells are under the influence of 2DG at constantly low ATP-levels, but the Golgi apparatus is maintained in forms of the Golgi bodies and Golgi stacks can be rebuilt as soon as 2DG is removed. The 3D-electron microscopic results highlight connecting regions that interlink membrane compartments in all phases of Golgi stack reorganizations and show that the compact Golgi bodies mainly consist of continuous intertwined tubules. Connections and continuities point to possible new transport pathways that could substitute for other modes of traffic. The changing architectures visualized in this work reflect Golgi stack dynamics that may be essential for basic cell physiologic and pathologic processes and help to learn, how cells respond to conditions of stress.


Assuntos
Carcinoma Hepatocelular/ultraestrutura , Desoxiglucose/metabolismo , Tomografia com Microscopia Eletrônica , Complexo de Golgi/metabolismo , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patologia , Células Hep G2 , Humanos , Células Tumorais Cultivadas
10.
Ultrastruct Pathol ; 41(3): 209-226, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28494215

RESUMO

Hepatitis C virus represents one of the rising causes of hepatocellular carcinoma (HCC). Although the early diagnosis of HCC is vital for successful curative treatment, the majority of lesions are diagnosed in an irredeemable phase. This work deals with a comparative ultrastructural study of experimentally gradually induced HCC, surgically resected HCC, and potential premalignant lesions from HCV-infected patients, with the prospect to detect cellular criteria denoting premalignant transformation. Among the main detected pathological changes which are postulated to precede frank HCC: failure of normal hepatocyte regeneration with star shape clonal fragmentation, frequent elucidation of hepatic progenitor cells and Hering canals, hepatocytes of different electron density loaded with small sized rounded monotonous mitochondria, increase junctional complexes bordering bile canaliculi and in between hepatocyte membranes, abundant cellular proteinaceous material with hypertrophied or vesiculated rough endoplasmic reticulum (RER), sequestrated nucleus with proteinaceous granular material or hypertrophied RER, formation of lipolysosomes, large autophagosomes, and micro-vesicular fat deposition. In conclusion, the present work has visualized new hepatocytic division or regenerative process that mimic splitting or clonal fragmentation that occurs in primitive creature. Also, new observations that may be of value or assist in predicting HCC and identifying the appropriate patient for surveillance have been reported. Moreover, it has pointed to the possible malignant potentiality of liver stem/progenitor cells. For reliability, the results can be subjected to cohort longitudinal study.


Assuntos
Carcinoma Hepatocelular/ultraestrutura , Hepatite C/complicações , Hepatócitos/ultraestrutura , Neoplasias Hepáticas/ultraestrutura , Carcinoma Hepatocelular/virologia , Diagnóstico Diferencial , Feminino , Hepatócitos/virologia , Humanos , Neoplasias Hepáticas/virologia , Masculino , Reprodutibilidade dos Testes , Células-Tronco/ultraestrutura
11.
Tsitologiia ; 59(3): 178-84, 2017.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-30183165

RESUMO

Hepatocellular carcinoma (HCC) is one of the aggressive and resistant to drug therapy cancer. It is believed that the development of HCC is correlated with dysregulation of programmed cell death. So, the search for effective inducers of HCC cell death is very important. The aim of the work was to identify structural changes leading to HCC cell death when exposed to nanoscale and original forms of lithium salts. Using light and electron microscopy and flow cytometry, structural features of autophagy and apoptosis in HCC cells after their incubation with various forms of lithium salts has been revealed. It is shown that a more pronounced effect on HCC-29 cells have nanoscale forms of lithium carbonate and lithium citrate. At the same time, nanoscale lithium citrate mainly induced apoptosis, and nanosized form of lithium carbonate, along with apoptosis, induced autophagic death of HCC-29cells.


Assuntos
Apoptose/efeitos dos fármacos , Autofagia/efeitos dos fármacos , Carcinoma Hepatocelular/metabolismo , Citratos/farmacologia , Carbonato de Lítio/farmacologia , Neoplasias Hepáticas/metabolismo , Nanopartículas , Animais , Carcinoma Hepatocelular/ultraestrutura , Linhagem Celular Tumoral , Feminino , Neoplasias Hepáticas/ultraestrutura , Camundongos , Camundongos Endogâmicos CBA
12.
Biochem Biophys Res Commun ; 479(2): 245-252, 2016 10 14.
Artigo em Inglês | MEDLINE | ID: mdl-27638305

RESUMO

A direct acting anti-Ebola agent is needed. VP40, a conserved protein across Ebolavirus (EBOV) species has several pivotal roles in the virus life cycle. Inhibition of VP40 functions would lessen the virion integrity and interfere with the viral assembly, budding, and spread. In this study, cell penetrable human scFvs (HuscFvs) that bound to EBOV VP40 were produced by phage display technology. Gene sequences coding for VP40-bound-HuscFvs were subcloned from phagemids into protein expression plasmids downstream to a gene of cell penetrating peptide, i.e., nonaarginine (R9). By electron microscopy, transbodies from three clones effectively inhibited egress of the Ebola virus-like particles from human hepatic cells transduced with pseudo-typed-Lentivirus particles carrying EBOV VP40 and GP genes. Computerized simulation indicated that the effective HuscFvs bound to multiple basic residues in the cationic patch of VP40 C-terminal domain which are important in membrane-binding for viral matrix assembly and virus budding. The transbodies bound also to VP40 N-terminal domain and L domain peptide encompassed the PTAPPEY (WW binding) motif, suggesting that they might confer VP40 function inhibition through additional mechanism(s). The generated transbodies are worthwhile tested with authentic EBOV before developing to direct acting anti-Ebola agent for preclinical and clinical trials.


Assuntos
Ebolavirus/efeitos dos fármacos , Anticorpos de Cadeia Única/farmacologia , Proteínas da Matriz Viral/imunologia , Liberação de Vírus/efeitos dos fármacos , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/ultraestrutura , Carcinoma Hepatocelular/virologia , Linhagem Celular Tumoral , Ebolavirus/fisiologia , Ebolavirus/ultraestrutura , Interações Hospedeiro-Patógeno , Humanos , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/ultraestrutura , Neoplasias Hepáticas/virologia , Microscopia Eletrônica de Varredura , Modelos Moleculares , Biblioteca de Peptídeos , Ligação Proteica , Domínios Proteicos , Anticorpos de Cadeia Única/química , Anticorpos de Cadeia Única/imunologia , Proteínas da Matriz Viral/química , Proteínas da Matriz Viral/genética , Vírion/efeitos dos fármacos , Vírion/fisiologia , Vírion/ultraestrutura , Liberação de Vírus/fisiologia
13.
Pharm Biol ; 54(8): 1445-57, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26810384

RESUMO

Context 2a,-3a,-24-Trihydroxyurs-12-en-28-oic acid (TEO, a corosolic acid analogue) is a triterpenoid saponin isolated from Actinidia valvata Dunn (Actinidiaceae), a well-known traditional Chinese medicine. Objective This study investigated the anti-proliferation and inducing apoptosis effects of TEO in three human hepatocellular carcinoma (HCC) cell lines. Materials and methods Cytotoxic activity of TEO was determined by the MTT assay at various concentrations from 2.5 to 40 µg/mL in BEL-7402, BEL-7404 and SMMC-7721 cell lines. Cell morphology was assessed by acridine orange/ethidium bromide and 4'-6-diamidino-2-phenylindole dihydrochloride staining and fluorescence microscopy. Cell-cycle distribution and DNA damage were determined by flow cytometry and comet assay. Mitochondrial dysfunction was assessed by JC-1 staining and transmission electron microscopy. Apoptosis changes were explored by Western blot, TNF-α and caspase-3, -8, -9 assays. Results TEO exhibited inhibition effects on BEL-7402, BEL-7404 and SMMC-7721 cells treated for 24 h, the IC50 values were 34.6, 30.8 and 30.5 µg/mL, respectively. TEO (40 µg/mL)-treated three cell lines increased by more than 21% in the G1 phase and presented the morphological change and DNA damage. TEO also declined the mitochondrial membrane potential and altered mitochondrial ultra-structure. Furthermore, caspase-3, caspase-8, caspase-9 and TNF-α were also activated. Mechanism investigation showed that TEO could decrease anti-apoptotic Bcl-2 protein expression, increase proapoptotic Bax and Bid proteins expressions and increase Bax/Bcl-2 ratio. Conclusion Our results demonstrate for the first time that TEO inhibited growth of HCC cell lines and induced G1 phase arrest. Moreover, proapoptotic effects of TEO were mediated through the activation of TNF-α, caspases and mitochondrial pathway.


Assuntos
Actinidia , Antineoplásicos Fitogênicos/farmacologia , Apoptose/efeitos dos fármacos , Carcinoma Hepatocelular/tratamento farmacológico , Neoplasias Hepáticas/tratamento farmacológico , Mitocôndrias Hepáticas/efeitos dos fármacos , Extratos Vegetais/farmacologia , Triterpenos/farmacologia , Actinidia/química , Proteínas Reguladoras de Apoptose/metabolismo , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/ultraestrutura , Linhagem Celular Tumoral , Forma Celular/efeitos dos fármacos , Dano ao DNA , Relação Dose-Resposta a Droga , Pontos de Checagem da Fase G1 do Ciclo Celular/efeitos dos fármacos , Humanos , Concentração Inibidora 50 , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/ultraestrutura , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Mitocôndrias Hepáticas/metabolismo , Mitocôndrias Hepáticas/ultraestrutura , Fitoterapia , Extratos Vegetais/isolamento & purificação , Plantas Medicinais , Transdução de Sinais/efeitos dos fármacos , Fatores de Tempo , Triterpenos/isolamento & purificação , Fator de Necrose Tumoral alfa/metabolismo
14.
Abdom Imaging ; 39(6): 1202-12, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24869790

RESUMO

PURPOSE: To retrospectively determine the correlation between heptic tumor signal intensity on gadoxetic acid-enhanced and diffusion-weighted MR images and histopathological grading of hepatocellular carcinoma (HCC). METHODS: We retrospectively reviewed the MR images of 79 patients with 141 surgically resected HCCs. The signal intensity and its relationship with histopathological grade were assessed. We measured the apparent diffusion correlation (ADC) values and calculated arterial enhancement ratios, washout ratios, and relative intensity ratios of HCCs relative to the surrounding liver parenchyma in gadoxetic-enhanced MR images in order to determine their relationship to the histological grade. RESULTS: Morphological evaluation showed that larger tumor size and extrahepatic extension were associated with higher histologic grade (p < 0.01). Multivariate logistic regression showed that low ADC value and low relative intensity ratio in the arterial phase (RIRa) predict high histological grade. ADC value (cut-off 1.7 × 10(-3) mm(2)/s, sensitivity 82.4%, specificity 83.2%) was the best predictor of well-differentiated HCC, and RIRa (cut-off 0.93, sensitivity 81.4%, specificity 93.9%) was superior to ADC for predicting poorly differentiated HCC. CONCLUSION: Relative low arterial enhancement on gadoxetic acid-enhanced MR images and low ADC are predictive of worse histological grades of HCC.


Assuntos
Carcinoma Hepatocelular/patologia , Meios de Contraste , Imagem de Difusão por Ressonância Magnética/métodos , Gadolínio DTPA , Aumento da Imagem/métodos , Neoplasias Hepáticas/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Hepatocelular/ultraestrutura , Feminino , Humanos , Fígado/patologia , Neoplasias Hepáticas/ultraestrutura , Masculino , Pessoa de Meia-Idade , Gradação de Tumores/métodos , Estudos Retrospectivos , Sensibilidade e Especificidade
15.
Surg Today ; 44(7): 1359-66, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23828653

RESUMO

We report a case of typical fibrolamellar hepatocellular carcinoma (FL-HCC) in a 16-year-old Japanese boy. This is very rare malignancy in Japan. The patient was referred for investigation of a large hepatic tumor and the results of tests for hepatitis B virus surface antigen and hepatitis C virus antibody were negative. Liver function test results and serum alpha-fetoprotein (AFP) levels were normal; however, the prothrombin induced by vitamin K absence/antagonist II was elevated. Computed tomography (CT) showed a large lobulated heterogeneously enhanced tumor in the posterior section of the liver. We diagnosed FL-HCC and performed posterior sectionectomy of the liver. The resected specimen contained a light brown and green tumor with a central fibrous scar, 10.0 cm in diameter. Microscopic and electron microscopic examinations revealed the typical features of FL-HCC. Immunohistochemically, the tumor cells were positive for cytokeratin (CK) 7, but negative for CK19 and AFP. The patient was alive without recurrence 48 months after surgery. Following this case report, we summarize the clinical features of the Japanese cases documented in the literature.


Assuntos
Carcinoma Hepatocelular/cirurgia , Neoplasias Hepáticas/cirurgia , Adolescente , Povo Asiático , Biomarcadores Tumorais/análise , Carcinoma Hepatocelular/diagnóstico , Carcinoma Hepatocelular/ultraestrutura , Hepatectomia , Humanos , Imuno-Histoquímica , Queratina-7/análise , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/ultraestrutura , Imageamento por Ressonância Magnética , Masculino , Microscopia Eletroquímica de Varredura , Protrombina/metabolismo , Tomografia Computadorizada por Raios X , Resultado do Tratamento
16.
Mol Cell Biochem ; 381(1-2): 127-37, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23703028

RESUMO

Endoplasmic reticulum stress (ERS) has been found in non-alcoholic fatty liver disease. The study was to further explore the mechanistic relationship between ERS and lipid accumulation. To induce ERS, the hepatoblastoma cell line HepG2 and the normal human L02 cell line were exposed to Tg for 48 h. RT-PCR and Western blot were performed to evaluate glucose-regulated protein (GRP-78) expression as a marker of ERS. ER ultrastructure was assessed by electron microscopy. Triglyceride content was examined by Oil Red O staining and quantitative intracellular triglyceride assay. The hepatic nuclear sterol regulatory element-binding protein (SREBP-1c), liver X receptor (LXRs), fatty acid synthase (FAS), and acetyl-coA carboxylase (ACC1) expressions were examined by real-time PCR and Western blot. 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF) was used to inhibit S1P serine protease inhibitor, and SREBP-1c cleavage was evaluated under ERS. SREBP-1c was knockdown and its effect on lipid metabolism was observed. Tg treatment upregulated GRP-78 expression and severely damaged the ER structure in L02 and HepG2 cells. ERS increased triglyceride deposition and enhanced the expression of SREBP-1c, FAS, and ACC1, but have no influence on LXR. AEBSF pretreatment abolished Tg-induced SREBP-1c cleavage. Moreover, SREBP-1c silencing reduced triglycerides and downregulated FAS expression. Pharmacological ERS induced by Tg leads to lipid accumulation through upregulation of SREBP-1c in L02 and HepG2 cells.


Assuntos
Carcinoma Hepatocelular/metabolismo , Estresse do Retículo Endoplasmático , Metabolismo dos Lipídeos , Neoplasias Hepáticas/metabolismo , Fígado/metabolismo , Proteína de Ligação a Elemento Regulador de Esterol 1/genética , Regulação para Cima , Acetil-CoA Carboxilase/metabolismo , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/ultraestrutura , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Retículo Endoplasmático/efeitos dos fármacos , Retículo Endoplasmático/ultraestrutura , Chaperona BiP do Retículo Endoplasmático , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Estresse do Retículo Endoplasmático/genética , Ácido Graxo Sintases/metabolismo , Fígado Gorduroso/patologia , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Técnicas de Silenciamento de Genes , Proteínas de Choque Térmico/metabolismo , Humanos , Metabolismo dos Lipídeos/efeitos dos fármacos , Metabolismo dos Lipídeos/genética , Fígado/efeitos dos fármacos , Fígado/patologia , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/ultraestrutura , Receptores X do Fígado , Receptores Nucleares Órfãos/genética , Receptores Nucleares Órfãos/metabolismo , Proteólise/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Proteína de Ligação a Elemento Regulador de Esterol 1/metabolismo , Sulfonas/farmacologia , Tapsigargina/farmacologia , Triglicerídeos/metabolismo , Regulação para Cima/efeitos dos fármacos
17.
Biol Pharm Bull ; 36(6): 938-43, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23502934

RESUMO

This study was designed to explore the effects of Musca domestica antimicrobial peptides cecropin on the adhesion and migration of human hepatocellular carcinoma BEL-7402 cells. The adhesive and migratory capacities were determined by adhesion assay and transwell assay, respectively. The changes in microvilli of tumor cells were determined by scanning electron microscopy (SEM). Western blotting and quantitative polymerase chain reaction (qPCR) were carried out to determine the expression levels of proteins related to adhesion and migration, such as matrix metalloproteinase-2 (MMP2), tissue inhibitors of metalloproteinase-2 (TIMP2), and epithelial cadherin (E-cadherin). We found that Musca domestica cecropin inhibited the adhesion and migration of BEL-7402 cells, which also displayed curling microvilli, increased ball structures on cell surface, gradually broken connections between tumor cells, and even disappeared microvilli on some cells. The expression of MMP2 was significantly reduced after cecropin treatment, while the levels of TIMP2 and E-cadherin were significantly increased. These results suggest that Musca domestica cecropin inhibits the adhesion and migration of human hepatocellular carcinoma BEL-7402 cells by destroying the microvilli of tumor cells and changing the expression of MMP2, TIMP2 and E-cadherin.


Assuntos
Carcinoma Hepatocelular/patologia , Cecropinas/farmacologia , Neoplasias Hepáticas/patologia , Animais , Caderinas/genética , Caderinas/metabolismo , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/ultraestrutura , Adesão Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Moscas Domésticas , Humanos , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/ultraestrutura , Metaloproteinase 2 da Matriz/genética , Metaloproteinase 2 da Matriz/metabolismo , Microscopia Eletrônica de Varredura , Microvilosidades/efeitos dos fármacos , Microvilosidades/ultraestrutura , RNA Mensageiro/metabolismo , Inibidor Tecidual de Metaloproteinase-2/genética , Inibidor Tecidual de Metaloproteinase-2/metabolismo
18.
Ultraschall Med ; 34(1): 11-29, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23129518

RESUMO

Initially, a set of guidelines for the use of ultrasound contrast agents was published in 2004 dealing only with liver applications. A second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some non-liver applications. Time has moved on, and the need for international guidelines on the use of CEUS in the liver has become apparent. The present document describes the third iteration of recommendations for the hepatic use of contrast enhanced ultrasound (CEUS) using contrast specific imaging techniques. This joint WFUMB-EFSUMB initiative has implicated experts from major leading ultrasound societies worldwide. These liver CEUS guidelines are simultaneously published in the official journals of both organizing federations (i.e., Ultrasound in Medicine and Biology for WFUMB and Ultraschall in der Medizin/European Journal of Ultrasound for EFSUMB). These guidelines and recommendations provide general advice on the use of all currently clinically available ultrasound contrast agents (UCA). They are intended to create standard protocols for the use and administration of UCA in liver applications on an international basis and improve the management of patients worldwide.


Assuntos
Carcinoma Hepatocelular/ultraestrutura , Meios de Contraste/administração & dosagem , Aumento da Imagem/métodos , Interpretação de Imagem Assistida por Computador/métodos , Hepatopatias/diagnóstico por imagem , Neoplasias Hepáticas/diagnóstico por imagem , Fígado/diagnóstico por imagem , Anafilaxia/induzido quimicamente , Anafilaxia/mortalidade , Biópsia por Agulha/métodos , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/cirurgia , Transformação Celular Neoplásica/patologia , Contraindicações , Meios de Contraste/efeitos adversos , Diagnóstico Diferencial , Hipersensibilidade a Drogas/etiologia , Hipersensibilidade a Drogas/mortalidade , Interações Medicamentosas , Compostos Férricos/efeitos adversos , Fluorocarbonos/efeitos adversos , Humanos , Ferro/efeitos adversos , Fígado/patologia , Fígado/cirurgia , Cirrose Hepática/diagnóstico por imagem , Cirrose Hepática/patologia , Hepatopatias/patologia , Hepatopatias/cirurgia , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/cirurgia , Transplante de Fígado/patologia , Óxidos/efeitos adversos , Fosfolipídeos/efeitos adversos , Fatores de Risco , Hexafluoreto de Enxofre/efeitos adversos , Ultrassonografia Doppler/métodos , Ultrassonografia de Intervenção/métodos
19.
Int J Mol Sci ; 14(1): 1370-82, 2013 Jan 11.
Artigo em Inglês | MEDLINE | ID: mdl-23344047

RESUMO

The traditional Chinese medicine bufalin, extracted from toad's skin, has been demonstrated to exert anticancer activities in various kinds of human cancers. The mechanisms of action lie in its capacity to induce apoptosis, or termed type I programmed cell death (PCD). However, type II PCD, or autophagy, participates in cancer proliferation, progression, and relapse, as well. Recent studies on autophagy seem to be controversial because of the dual roles of autophagy in cancer survival and death. In good agreement with previous studies, we found that 100 nM bufalin induced extensive HepG2 cell apoptosis. However, we also noticed bufalin triggered autophagy and enhanced Beclin-1 expression, LC3-I to LC3-II conversion, as well as decreased p62 expression and mTOR signaling activation in HepG2 cells. Blockage of autophagy by selective inhibitor 3-MA decreased apoptotic ratio in bufalin-treated HepG2 cells, suggesting a proapoptotic role of bufalin-induced autophagy. Furthermore, we investigated the underlying mechanisms of bufalin-induced autophagy. Bufalin treatment dose-dependently promoted AMPK phosphorylation while AMPK inhibition by compound C significantly attenuated bufalin-induced autophagy. Taken together, we report for the first time that bufalin induces HepG2 cells PCD, especially for autophagy, and the mechanism of action is, at least in part, AMPK-mTOR dependent.


Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Autofagia/efeitos dos fármacos , Bufanolídeos/farmacologia , Proteínas Quinases Ativadas por AMP/metabolismo , Antineoplásicos/química , Proteínas Reguladoras de Apoptose/metabolismo , Proteína Beclina-1 , Western Blotting , Bufanolídeos/química , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/ultraestrutura , Proliferação de Células/efeitos dos fármacos , Relação Dose-Resposta a Droga , Células Hep G2 , Humanos , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/ultraestrutura , Proteínas de Membrana/metabolismo , Microscopia Confocal , Microscopia Eletrônica de Transmissão , Proteínas Associadas aos Microtúbulos/metabolismo , Estrutura Molecular , Fosforilação/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Serina-Treonina Quinases TOR/metabolismo
20.
Zhonghua Bing Li Xue Za Zhi ; 42(9): 604-8, 2013 Sep.
Artigo em Zh | MEDLINE | ID: mdl-24314246

RESUMO

OBJECTIVE: To compare morphological differences of three drug-resistant hepatocellular carcinoma (HCC) cell subclones (Huh-7/ADM, Huh-7/CBP, Huh-7/MMC) and their parental Huh-7 cell line, to analyze differential microRNA (miRNA) expression profiles in these cells and, finally to screen for the abnormal expressed miRNAs in drug-resistant HCC cells. METHODS: Cellular morphology was observed by histology and transmission electron microscopy. MiRNA microarray was used to analyze the differential miRNA expression profiles in these cells (Huh-7, Huh-7/ADM, Huh-7/CBP, Huh-7/MMC) followed by real time quantitative PCR validation. RESULTS: The drug-resistant cells had more intracytoplasmic organelles and were larger in size along with increased cytological pleomorphism than the parental Huh-7 cells. Compared with the parental Huh-7 cells, 32 simultaneously up-regulated and 22 down-regulated miRNAs were found in three drug-resistant cells. Up-regulation of miR-15a, miR-16, miR-27b, miR-30b, miR-146a, miR-146b-5p, miR-181a, miR-181d and miR-194 was verified by RT-qPCR. CONCLUSION: Drug-resistant HCC cells have abnormal expressed miRNAs, which may be explored to further investigate the association of miRNA expressions with multidrugs resistance in HCC.


Assuntos
Carcinoma Hepatocelular/genética , Resistencia a Medicamentos Antineoplásicos , Perfilação da Expressão Gênica , Neoplasias Hepáticas/genética , MicroRNAs/genética , Antineoplásicos/farmacologia , Carboplatina/farmacologia , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/ultraestrutura , Linhagem Celular Tumoral , Doxorrubicina/farmacologia , Resistência a Múltiplos Medicamentos , Humanos , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/ultraestrutura , MicroRNAs/metabolismo , Mitomicina/farmacologia , Análise de Sequência com Séries de Oligonucleotídeos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA